Tilray Brands TLRY
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
Key Insights
Tilray Brands (TLRY) Core Market Data and Business Metrics
Latest Closing Price
$0.6514Price-Earnings Ratio
-2.17Total Outstanding Shares
937.66 Million SharesDividend
No dividendSIC Description
Medicinal Chemicals & Botanical ProductsPrimary Exchange
NASDAQHeadquarters
655 Madison Avenue, New York, NY, 10065
Historical Stock Splits
Execution Date | Split Amount |
---|---|
No Historical Stock Splits |
Short Interest
Track Short Interest Levels to Gauge Bearish Market Sentiment and Short Squeeze Potential
Avg Daily Volume | Days to Cover | Settlement Date | Short Interest |
---|---|---|---|
40,740,541 Shares | 4.08 | 3/14/2025 | 166,289,607 Shares |
43,828,865 Shares | 3.7 | 2/28/2025 | 162,138,718 Shares |
55,260,950 Shares | 2.55 | 2/14/2025 | 141,025,738 Shares |
41,973,907 Shares | 2.92 | 1/31/2025 | 122,606,168 Shares |
44,927,134 Shares | 2.98 | 1/15/2025 | 133,886,057 Shares |
40,082,643 Shares | 3.02 | 12/31/2024 | 121,196,227 Shares |
Cash Flow Statement
December 1, 2023 to November 30, 2024
Metric | Value |
---|---|
Net Cash Flow From Operating Activities | $-60.69 Million |
Net Cash Flow From Operating Activities, Continuing | $-60.69 Million |
Net Cash Flow From Financing Activities, Continuing | $94.95 Million |
Net Cash Flow From Financing Activities | $94.95 Million |
Net Cash Flow From Investing Activities | $13.02 Million |
Net Cash Flow From Investing Activities, Continuing | $13.02 Million |
Income Statement
December 1, 2023 to November 30, 2024
Metric | Value |
---|---|
Revenues | $829.22 Million |
Net Income/Loss Available To Common Stockholders, Basic | $-248.96 Million |
Diluted Average Shares | $2.51 Billion |
Net Income/Loss Attributable To Parent | $-248.96 Million |
Research and Development | $665,000 |
Costs And Expenses | $1.10 Billion |
Comprehensive Income
December 1, 2023 to November 30, 2024
Metric | Value |
---|---|
Comprehensive Income/Loss | $-250.38 Million |
Other Comprehensive Income/Loss | $-10.10 Million |
Comprehensive Income/Loss Attributable To Noncontrolling Interest | $8.16 Million |
Comprehensive Income/Loss Attributable To Parent | $-258.55 Million |
Balance Sheet
December 1, 2023 to November 30, 2024
Metric | Value |
---|---|
Accounts Payable | $99.08 Million |
Current Liabilities | $278.52 Million |
Inventory | $266.01 Million |
Assets | $4.19 Billion |
Other Current Assets | $441.33 Million |
Wages | $4.52 Million |
Historical Dividends
Announcement Date | Payment Date | Record Date | Amount | Frequency |
---|---|---|---|---|
No historical dividends |